BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24153061)

  • 1. Foamy virus vectors for HIV gene therapy.
    Olszko ME; Trobridge GD
    Viruses; 2013 Oct; 5(10):2585-600. PubMed ID: 24153061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.
    Kiem HP; Wu RA; Sun G; von Laer D; Rossi JJ; Trobridge GD
    Gene Ther; 2010 Jan; 17(1):37-49. PubMed ID: 19741733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
    Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
    Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
    Rethwilm A
    Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and prediction of the HIV-1 central polypurine tract influence on foamy viral vectors to transduce dividing and growth-arrested cells.
    Shityakov S; Förster C; Rethwilm A; Dandekar T
    ScientificWorldJournal; 2014; 2014():487969. PubMed ID: 25009830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foamy virus vectors for gene transfer.
    Trobridge GD
    Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the in vivo safety of insulated foamy viral vectors.
    Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
    Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of simian foamy virus type-1 vectors.
    Park J; Mergia A
    Cold Spring Harb Protoc; 2011 Sep; 2011(9):. PubMed ID: 21880822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline foamy virus-based vectors: advantages of an authentic animal model.
    Liu W; Lei J; Liu Y; Lukic DS; Räthe AM; Bao Q; Kehl T; Bleiholder A; Hechler T; Löchelt M
    Viruses; 2013 Jul; 5(7):1702-18. PubMed ID: 23857307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large animal models for foamy virus vector gene therapy.
    Trobridge GD; Horn PA; Beard BC; Kiem HP
    Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection.
    Trobridge GD; Wu RA; Beard BC; Chiu SY; Muñoz NM; von Laer D; Rossi JJ; Kiem HP
    PLoS One; 2009 Nov; 4(11):e7693. PubMed ID: 19888329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foamy virus vectors.
    Mergia A; Heinkelein M
    Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.
    Nalla AK; Trobridge GD
    Biomedicines; 2016 Mar; 4(2):. PubMed ID: 28536375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs.
    Simantirakis E; Tsironis I; Vassilopoulos G
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32204324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus and foamy virus vectors: novel gene therapy tools.
    Pandya S; Klimatcheva E; Planelles V
    Expert Opin Biol Ther; 2001 Jan; 1(1):17-40. PubMed ID: 11727544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
    Trobridge GD; Beard BC; Wu RA; Ironside C; Malik P; Kiem HP
    PLoS One; 2012; 7(9):e45173. PubMed ID: 23028826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral vector interactions with hematopoietic cells.
    Everson EM; Trobridge GD
    Curr Opin Virol; 2016 Dec; 21():41-46. PubMed ID: 27521874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of large transgene cassettes by foamy virus vector.
    Sweeney NP; Meng J; Patterson H; Morgan JE; McClure M
    Sci Rep; 2017 Aug; 7(1):8085. PubMed ID: 28808269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.
    Stirnnagel K; Lüftenegger D; Stange A; Swiersy A; Müllers E; Reh J; Stanke N; Grosse A; Chiantia S; Keller H; Schwille P; Hanenberg H; Zentgraf H; Lindemann D
    Retrovirology; 2010 May; 7():45. PubMed ID: 20478027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.